Improving Mental Health Treatment Through Pharmacogenomics
RadioRev interviews CLS' President & CEO, Scott Megill
Listen here or wherever you get your podcasts: coriell.com/PGxForMentalHealth
Coriell Life Sciences’ (CLS) President and CEO, Scott Megill, joins the season 3 premiere of Icario Health‘s RadioRev to talk about pharmacogenomics (PGx) and how it relates to mental health care. In this episode, Scott discusses some of the silver linings that emerged over the last year in healthcare and pharmacogenomics in psychiatry.
- CLS’ unique approach.
- The role of personalization in CLS’ work.
- How PGx improves mental health treatment
Learn more about pharmacogenomics and mental health.
Connect with Scott directly on LinkedIn.
Last Updated: March 17, 2022